Skip to Content

Hydroxychloroquine

In the US, Hydroxychloroquine (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lyme Disease - Arthritis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus and Undifferentiated Connective Tissue Disease.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01BA02

CAS registry number (Chemical Abstracts Service)

0000118-42-3

Chemical Formula

C18-H26-Cl-N3-O

Molecular Weight

336

Therapeutic Categories

Antiprotozoal agent: Antimalarial

Disease-modifying antirheumatic drug, DMARD

Chemical Name

Etanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]etylamino]-

Foreign Names

  • Hydroxychloroquinum (Latin)
  • Hydroxychloroquin (German)
  • Hydroxychloroquine (French)
  • Hidroxicloroquina (Spanish)

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.